0001209191-22-058270.txt : 20221121
0001209191-22-058270.hdr.sgml : 20221121
20221121185316
ACCESSION NUMBER: 0001209191-22-058270
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20221117
FILED AS OF DATE: 20221121
DATE AS OF CHANGE: 20221121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: de la Torre Ralph
CENTRAL INDEX KEY: 0001954632
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39391
FILM NUMBER: 221407077
MAIL ADDRESS:
STREET 1: 4939 BROOKVIEW DRIVE
CITY: DALLAS
STATE: TX
ZIP: 75220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareMax, Inc.
CENTRAL INDEX KEY: 0001813914
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
IRS NUMBER: 850992224
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 NW 57 COURT, SUITE 400
CITY: MIAMI
STATE: FL
ZIP: 33126
BUSINESS PHONE: 786-360-4768
MAIL ADDRESS:
STREET 1: 1000 NW 57 COURT, SUITE 400
CITY: MIAMI
STATE: FL
ZIP: 33126
FORMER COMPANY:
FORMER CONFORMED NAME: Deerfield Healthcare Technology Acquisitions Corp.
DATE OF NAME CHANGE: 20200602
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-17
0
0001813914
CareMax, Inc.
CMAX
0001954632
de la Torre Ralph
4939 BROOKVIEW DRIVE
DALLAS
TX
75220
1
0
1
0
Restricted Stock Units
0.00
2022-11-17
4
A
0
10927
0.00
A
Class A Common Stock
10927
10927
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's Class A common stock in accordance with the issuer's 2021 Long-Term Incentive Plan. The RSUs will vest on November 17, 2023 if on such date the reporting person has remained in continuous service as a director.
See Exhibit 24 - Power of Attorney
/s/ Meredith Longsworth, Esq., as attorney-in-fact for Ralph de la Torre
2022-11-21
EX-24
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes, constitutes and
appoints Meredith Longsworth and Kevin Wirges, and each of them signing singly,
and with full power of substitution and resubstitution, each with the power to
act alone for the undersigned and in the undersigned's name, place and stead, in
any and all capacities to:
(1) with respect to the equity securities of CareMax, Inc., a Delaware
corporation (the "Company"), prepare, execute, acknowledge, deliver and file
with the United States Securities and Exchange Commission (the "SEC"), any
national securities exchanges and the Company, (i) a Form ID, and any amendments
thereto, Update Passphrase Confirmation, and any other documents necessary or
appropriate to obtain codes and passwords enabling the undersigned to make
electronic filings with the SEC, and (ii) any and all reports (including Forms
3, 4, and 5) and any amendments thereto, as considered necessary or advisable
under Section 16(a) of the Securities Exchange Act of 1934 and the rules and
regulations promulgated thereunder, as amended from time to time (the "Exchange
Act");
(2) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information regarding transactions in the Company's equity securities
from any third party, including the Company and any brokers, dealers, employee
benefit plan administrators and trustees, and the undersigned hereby authorizes
any such person to release any such information to the undersigned and approves
and ratifies any such release of information; and
(3) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in his or her discretion on information provided to such
attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirements of Section 16
of the Exchange Act, (ii) any liability of the undersigned for any failure to
comply with such requirements, or (iii) any obligation or liability of the
undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under Section 16 of the
Exchange Act, including without limitation the reporting requirements under
Section 16 of the Exchange Act.
The undersigned hereby gives and grants the foregoing attorneys-in-fact, and
each of them, full power and authority to do and perform any and every act and
thing whatsoever requisite, necessary or appropriate to be done in and about the
foregoing matters as fully to all intents and purposes as the undersigned might
or could do if present, with full power of substitution and re-substitution,
hereby ratifying and confirming all that such attorney-in-fact, or his or her
substitute or substitutes, shall lawfully do or cause to be done by authority of
this Power of Attorney.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file reports (including Forms 3, 4 and 5)
under Section 16 of the Exchange Act with respect to the undersigned's
transactions in equity securities of the Company, unless earlier revoked by the
undersigned in a signed writing delivered to such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 21 day of November, 2022.
/s/ Ralph de la Torre
Ralph de la Torre